FAIRFIELD, N.J., Jan. 15, 2012 /PRNewswire/ -- Aperture Health, Inc. (OTC APRE.PK) announced that it has completed the acquisition of Triad Therapeutics, Inc., ("Triad") a homecare infusion therapy and nursing provider in New Jersey serving the tri-state area. As a result, Triad has become a wholly owned subsidiary of Aperture Health, Inc., and will remain as the operating company for the combined business.
Triad provides specialized home healthcare services to patients requiring intravenous therapy including antibiotics, pain management, hydration, immunoglobulins, steroids, total nutritional solutions, and IV catheter insertions and maintenance. The Company provides a complete solution to patients including the preparation and delivery of sterile compounded IV medications, supplies and equipment, along with specialized nursing care and teaching of the patient and/or caregivers on the administration of therapies as prescribed by a physician.
Triad is a fully JCAHO accredited home IV therapy company, achieving this "gold standard" status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the states of New Jersey, New York and Connecticut, providing opportunity for organic growth. Triad's full time marketing and sales personnel continuously represent the company in the core services areas, growing and maintaining the company's referral source base. Patient referrals are made from physicians, hospitals, insurance companies, veterinarians and hospice care providers that have established a professional rapport with Triad.
All patient clients accepted to Triad's service have been preapproved for care by the client's health insurance provider. Triad maintains numerous managed care service provider contracts, many of which are part of "closed networks," thus provide strong barriers to entry in the industry.
The business of home infusion therapy is a mature industry with multiple competitors. Triad markets its services to hospital discharge planners, physicians, hospice providers, and veterinarian hospitals. Triad vigorously and successfully competes for client referrals by providing enhanced customer service and reliable cross communication with the patients care givers, nurses, pharmacists and physicians.
James Hennig, R.Ph, Chief Executive Officer and Chairman of the Board of Directors commented, "We are very pleased to become a U.S. publicly listed company which will contribute to our market awareness and provide a platform for the capital necessary for us to implement our growth strategy which includes acquisitions and other joint ventures, as well as, organic growth through new referral sources and product and service enhancements."
Aperture Health, Inc. Reverse Merger Transaction:
Aperture Health Inc. (The Company), a Nevada Corporation, was incorporated on Feb. 13th, 2001. On July 18, 2011, Triad Therapeutics Inc. merged into The Company via a reverse merger transaction as consideration for all of the issued and outstanding shares of Triad. The Triad shareholders received a 51% controlling interest in The Company. On Sept. 13, 2011, The Company executed a 1:500 reverse stock split and issued an additional 21 Million shares to Triad Shareholders. Triad is the sole operating entity. Triad was incorporated in Delaware in 2007.
The Company is in the process of updating their Pink Sheet Disclosure and encourages readers to review such information as it provides a more detailed status of the Company.
Safe Harbor
Certain statements in this news release are forward-looking, including (without limitation) growing revenues and earnings, expected results from current projects and attracting new business. Undue reliance should not be placed on such forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties and other unpredictable factors, many of which are beyond the Company's control. The Company's actual results, performance and trends could differ materially from those indicated or implied by such statements as a result of various factors, including (without limitation) the continued strengthening of Triad's selling and marketing functions, continued customer satisfaction, contract renewal, new product development, continued availability of capable dedicated personnel, continued cost management, success and availability of acquisitions, availability of financing and other factors, as well as by factors applicable to most companies such as general economic, competitive and other business and civil conditions. Information regarding certain of those and other risk factors and cautionary statements that could affect future results, performance or trends is discussed in the Company's OTC Disclosure Statement and unaudited management financials posted on www.pinksheets.com. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
No comments:
Post a Comment